Table 1 Baseline clinical characteristics of the study population stratified by EAT thickness.
Patients | EAT < median | EAT ≥ median | p value | |
|---|---|---|---|---|
N = 399 | N = 203 | N = 196 | ||
Age (years) | 60 ± 14 | 58 ± 14 | 62 ± 13 | 0.001 |
Sex (man) | 182 (46%) | 91 (45%) | 91 (46%) | 0.92 |
BMI (kg/m2) | 28 ± 6 | 27 ± 5 | 28 ± 6 | 0.15 |
Systolic RR (mmHg) | 135 ± 26 | 135 ± 26 | 136 ± 25 | 0.57 |
Diastolic RR (mmHg) | 69 ± 13 | 68 ± 13 | 69 ± 13 | 0.67 |
LDL (mg/dl) | 126 ± 40 | 126 ± 42 | 126 ± 37 | 0.95 |
HDL (mg/dl) | 55 ± 17 | 54 ± 15 | 55 ± 19 | 0.67 |
Triglyceride (mg/dl) | 145 ± 90 | 135 ± 77 | 156 ± 100 | 0.05 |
Antihypertensive drugs, n (%) | 235 (60) | 116 (57) | 119 (60) | 0.48 |
Lipid lowering drugs, n (%) | 145 (38) | 65 (33) | 80 (42) | 0.07 |
Active smoking, n (%) | 62 (16) | 32 (16) | 30 (16) | 0.89 |
Diabetes, n (%) | 57 (19) | 27 (14) | 30 (16) | 0.67 |
Family history, n (%) | 68 (18) | 33 (17) | 35 (18) | 0.79 |
EAT thickness (mm) | 4.8 ± 2.2 | 3.1 ± 0.7 | 6.5 ± 2 | <0.0001 |
